Lymphokine-Activated Tumor Inhibition (LATI) in Vivo

This publication has 42 references indexed in Scilit:

• A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
  Science, 1986
• Interferon‐activated tumor inhibition in vivo. Small amounts of interferon‐gamma inhibit tumor growth by eliciting host systemic immunoreactivity
  International Journal of Cancer, 1986
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985
• Synthesis and secretion of eosinophil granule substances
  Immunology Today, 1985
• Quantitative variation in la antigen expression plays a central role in immune regulation
  Immunology Today, 1984
• In vitro detection of cell‐mediated immunity to individual tumor‐specific antigens of chemically induced BALB/c fibrosarcomas
  International Journal of Cancer, 1983
• DISTINCT ALLOANTIGENS TRIGGER PROLIFERATIVE OR NONPROLIFERATIVE T LYMPHOCYTE ACTIVATION IN CBA/N, CBA/J, AND C3H MICE
  Transplantation, 1982
• Immune recognition of tumor cells in vivo. I. Role of H‐2 gene products in T lymphocyte activation against minor histocompatibility antigens displayed by adenocarcinoma cells
  European Journal of Immunology, 1982
• T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.
  The Journal of Experimental Medicine, 1980
• FUNCTION OF MACROPHAGES IN ANTIGEN RECOGNITION BY GUINEA PIG T LYMPHOCYTES
  The Journal of Experimental Medicine, 1973